Deficiency of CD36 in LECs highlights a new mechanism for the etiology of visceral obesity and insulin resistance, two phenotypes linked to the metabolic syndrome, which increases risk of cardiovascular disease and T2D, pathologies that associate with CD36 genetic variants66–68. The gene discussed is CD36; the disease is type 2 diabetes mellitus.